Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Celcuity (CELC) and Icon (ICLR)
Celcuity Analyst Ratings
Celcuity Inc: Needham cuts price target from $24.00 to $23.00
Stifel Maintains Buy on Celcuity, Maintains $40 Price Target
Craig-Hallum: Assuming a Celcuity (CELC.US) buy rating, the target price was adjusted from $25.00 to $27.00.
Craig-Hallum Assumes Celcuity at Buy, Raises Price Target to $27
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Celcuity (CELC) and 89bio (ETNB)
Celcuity Analyst Ratings
Celcuity's Clinical and Financial Momentum Justifies Buy Rating and $24 Price Target
Growth Potential Drives Buy Rating for Celcuity Despite Current Losses
Analysts Offer Insights on Healthcare Companies: Athira Pharma (ATHA), Celcuity (CELC) and ATAI Life Sciences (ATAI)
Needham: Reiterates Celcuity (CELC.US) rating and adjusted from buy to buy rating, target price is $24.00.
Celcuity Analyst Ratings
Celcuity Analyst Ratings
Craig-Hallum Maintains Buy on Celcuity, Raises Price Target to $25
Craig Hallum Adjusts Celcuity Price Target to $25 From $20, Maintains Buy Rating
Stifel Nicolaus Reaffirms Their Buy Rating on Celcuity (CELC)
HC Wainwright & Co. Reiterates Buy on Celcuity, Maintains $27 Price Target
Analysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Cara Therapeutics (CARA)
Celcuity Analyst Ratings
No Data